Genetic Mapping in Treating Modern Diseases

Abstract

Long read sequencing and Next-Generation Sequencing (NGS) are driving genetic mapping, which is transforming our knowledge of illnesses. These cutting-edge methods accurately detect genetic variants, ranging from single nucleotide polymorphisms to significant structural alterations, associated with diseases such as cancer, heart disease, and neurological problems. Importantly, genetic reference maps are completing the knowledge gaps regarding difficult genomic regions. One example of this is the UC Irvine Tandem Genome Aggregation Database, combining Machine Learning (ML) and Artificial Intelligence (AI) with genetic mapping, which is a significant advancement. AI systems examine enormous genomic information, identifying intricate patterns to more accurately forecast treatment response and illness risk. Precision oncology relies on this synergy to guide customized therapy based on individual tumor characteristics, which leads to greater results and fewer side effects. Together with CRISPR-Cas gene editing, this approach opens up new possibilities for fixing mutations that cause disease. Gene therapy studies are currently being conducted for diseases including sickle cell disease. Beyond single gene analysis, multi-omics integration which combines transcriptomic, proteomic, metabolomic, and genomic data offers a comprehensive perspective on disease, opening the door to highly individualized treatments, proactive risk management, early detection, and fully personalized medicine.